Phenoxybenzamine Hydrochloride (Par Pharmaceutical, Inc.)
Welcome to the PulseAid listing for the Phenoxybenzamine Hydrochloride drug offered from Par Pharmaceutical, Inc.. This Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Par Pharmaceutical, Inc. |
NON-PROPRIETARY NAME: | Phenoxybenzamine Hydrochloride |
SUBSTANCE NAME: | PHENOXYBENZAMINE HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | ANDA |
START MARKETING DATE: | 2017-01-24 |
END MARKETING DATE: | 0000-00-00 |
Phenoxybenzamine Hydrochloride HUMAN PRESCRIPTION DRUG Details:
Item Description | Phenoxybenzamine Hydrochloride from Par Pharmaceutical, Inc. |
LABELER NAME: | Par Pharmaceutical, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 10(mg/1) |
START MARKETING DATE: | 2017-01-24 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 49884-038_f87b03a4-ea46-4c56-b514-90067e630da7 |
PRODUCT NDC: | 49884-038 |
APPLICATION NUMBER: | ANDA204522 |
Other PHENOXYBENZAMINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: